-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Could this be the solution for Alzheimer’s Disease? =[L+MZ+Z+DHA+EPA] | Journal of Alzheimer's DiseaseShare Us: Subscribe | Contact -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Deep Brain Stimulation showing promise for patients with mild Alzheimer’s disease over age 65 | Journal of Alzheimer's DiseaseShare Us: Subscribe | Contact -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The potential dangers of the things that we often take granted like the air we breathe or in this case the water we drink, can be linked to brain damage that takes years to become clinically significant and therefore nearly impossible to pin down on. Animal research in Taiwan is indicating that ultrasound is a possible mitigator in protecting the…[Read more]
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The liver may be playing a larger role in the development of AD. The influx of possibilities can be both overwhelming and exciting but it always comes back to the systems of the body being just parts to a larger whole.
-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Human trials of Alzheimer 'cure' | Express.co.ukTHE FIRST human trials of a ground-breaking drug shown to repair DNA damage that contributes to Alzheimer’s disease will be launched this week, in a move s… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
A multi-state study is recruiting to investigate whether Posiphen, which inhibits the formation of toxic plaques opposed to removing after formation, is a viable treatment.
400 Bad RequestYour browser sent a request that this… -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
New Alzheimer's drug may slow decline, researchers reportThe drug helped slow the inevitable loss of clear thinking and memory that comes with the condition. -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
BAN2401, a new drug being developed by Biogen and Eisai shows exciting results in Phase 1 and Phase 2 trials with reduction of plaques and slowing the progression of AD by estimated 30%.…[Read more]
-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
New drug could slow down progression of Alzheimer’s.
New drug could slow down progression of Alzheimer’s – NBC NewsDrug maker Biogen reported today at a major Alzheimer’s conference that after 18 mon… -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Researchers at Georgetown University are currently recruiting participants to test the Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer’s Disease (AD)
400 Bad RequestYour browser sent a request that… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
Research centers in Massachusetts and New Hampshire are recruiting and researching the efficacy of auditory and visual stimulation on intervening in Alzheimer’s and dementia-related conditions.
400 Bad… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
Sometimes research news can be difficult to decipher. Within this research’s preliminary results, the rise and fall of estrogen within a woman’s life can be a potential target for potential and treatment.
-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Cutting your energy intake by fasting several days a week might help your brain ward off neurodegenerative diseases like Alzheimer’s and Parkinson’s while at the same time improving memory and mood.
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The first step of drug development often is to find a step, or protein, or something that’s unique to target but consistent within most cases. Researchers at Temple University are finding some preliminary success in animal trials that show some reversing of dementia-like symptoms.
Researchers reverse cognitive impairments in mice with… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
A New York research study is continuing the conversation in the relation between AD and Herpes in their current recruiting study.
400 Bad RequestYour browser sent a request that this server could not understand. -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Scientists fix genetic risk factor for Alzheimer's disease in human brain cells: New insights into how a gene causes damage could impact future drug development — ScienceDailyResearchers have revealed how apoE4 confers its risk for Alzheimer’s… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The inability to comprehensively treat Alzheimer’s results from the gap in knowledge about what Alzheimer’s is and how it develops. Dr. Yadong Huang’s research concerning the APOE4 protein is starting to shape that target which is the first step in our journey to finding a cure.
-
CarlsonTeke2 joined the group Alzheimer’s Disease Advocate Network
-
Eric Drew posted an update in the group Alzheimer’s Disease Advocate Network
Alzheimer's risk 10 times lower with herpes medicationNew… -
raineealexis joined the group Alzheimer’s Disease Advocate Network
- Load More